157 related articles for article (PubMed ID: 6828337)
1. Four-hydroxyphenylpyruvic acid oxidase deficiency with normal fumarylacetoacetase: a new variant form of hereditary hypertyrosinemia.
Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
Pediatr Res; 1983 Feb; 17(2):92-6. PubMed ID: 6828337
[TBL] [Abstract][Full Text] [Related]
2. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
[No Abstract] [Full Text] [Related]
3. [Hereditary tyrosinemia: examination of the liver by electron microscopy of hepatic biopsies: observation of 7 cases].
Tremblay M; Bélanger L; Larochelle J; Privé L; Gagnon PM
Union Med Can; 1977 Jul; 106(7):1014-6. PubMed ID: 898402
[No Abstract] [Full Text] [Related]
4. Metabolic studies on two patients with nonhepatic tyrosinemia using deuterated tyrosine loads.
Faull KF; Gan I; Halpern B; Hammond J; Im S; Cotton RG; Danks DM; Freeman R
Pediatr Res; 1977 May; 11(5):631-7. PubMed ID: 870870
[TBL] [Abstract][Full Text] [Related]
5. A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.
Endo F; Katoh H; Yamamoto S; Matsuda I
Am J Hum Genet; 1991 Apr; 48(4):704-9. PubMed ID: 2014797
[TBL] [Abstract][Full Text] [Related]
6. Enzyme defect in a case of tyrosinemia type I, acute form.
Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
[TBL] [Abstract][Full Text] [Related]
7. [Association, in the same subject, of deletion of the short arm of chromosome 4 (4p-) and of complete deficiency of parahydroxyphenyl-pyruvate oxidase activity in the liver (tyrosinosis)].
Malpuech G; Mattei JF; Gaulme J; Palcoux JB; Lesec G; Vanlieferinghen P
J Genet Hum; 1981 Dec; 29(4):455-61. PubMed ID: 7328420
[TBL] [Abstract][Full Text] [Related]
8. Hereditary tyrosinemia type I--an overview.
Kvittingen EA
Scand J Clin Lab Invest Suppl; 1986; 184():27-34. PubMed ID: 3296130
[TBL] [Abstract][Full Text] [Related]
9. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
Michals K; Matolon R; Wong PW
J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
[TBL] [Abstract][Full Text] [Related]
10. Sural nerve lesions in a case of hypertyrosinemia.
Origuchi Y; Endo F; Kitano A; Nagata N; Matsuda I
Brain Dev; 1982; 4(6):463-8. PubMed ID: 7168483
[TBL] [Abstract][Full Text] [Related]
11. Some biochemical effects of chloral hydrate in an infant with a tyrosinemia-like syndrome.
Watts RW; Chalmers RA; Liberman MM; Lawson AM
Pediatr Res; 1975 Dec; 9(12):875-8. PubMed ID: 1196703
[TBL] [Abstract][Full Text] [Related]
12. Parahydroxyphenylpyruvicacidemia in tyrosinosis.
Jaiswal RB; Bhai I; Daginawala HF; Nath N; Nath MC
Indian Pediatr; 1978 Nov; 15(11):893-9. PubMed ID: 36347
[No Abstract] [Full Text] [Related]
13. The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
Kvittingen EA; Brodtkorb E
Scand J Clin Lab Invest Suppl; 1986; 184():35-40. PubMed ID: 3473612
[TBL] [Abstract][Full Text] [Related]
14. Hereditary tyrosinemia type I: lack of correlation between clinical findings and amount of immunoreactive fumarylacetoacetase protein.
Kvittingen EA; Rootwelt H; van Dam T; van Faassen H; Berger R
Pediatr Res; 1992 Jan; 31(1):43-6. PubMed ID: 1594329
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
Berger R; Smit GP; Stoker-de Vries SA; Duran M; Ketting D; Wadman SK
Clin Chim Acta; 1981 Jul; 114(1):37-44. PubMed ID: 7249373
[TBL] [Abstract][Full Text] [Related]
16. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
Hostetter MK; Levy HL; Winter HS; Knight GJ; Haddow JE
N Engl J Med; 1983 May; 308(21):1265-7. PubMed ID: 6188953
[TBL] [Abstract][Full Text] [Related]
17. Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect.
Kvittingen EA; Rootwelt H; Brandtzaeg P; Bergan A; Berger R
J Clin Invest; 1993 Apr; 91(4):1816-21. PubMed ID: 8473520
[TBL] [Abstract][Full Text] [Related]
18. Deranged tyrosine metabolism in cirrhosis.
Fulenwider JT; Nordlinger BM; Faraj BA; Ivey GL; Rudman D
Yale J Biol Med; 1978; 51(6):625-33. PubMed ID: 36717
[TBL] [Abstract][Full Text] [Related]
19. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.
Endo F; Katoh H; Matsuda I
J Inherit Metab Dis; 1990; 13(5):780-2. PubMed ID: 2246865
[No Abstract] [Full Text] [Related]
20. Type I tyrosinemia: lack of immunologically detectable fumarylacetoacetase enzyme protein in tissues and cell extracts.
Berger R; Van Faassen H; Taanman JW; De Vries H; Agsteribbe E
Pediatr Res; 1987 Oct; 22(4):394-8. PubMed ID: 3317254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
